Fact-checked by Grok 2 weeks ago

Nitroxyl

Nitroxyl (HNO), also known as azanone, is a highly reactive species and the one-electron reduced and protonated form of (NO), featuring a bent triatomic structure with the formula H–N=O, where the nitrogen-oxygen is approximately 1.212 and the H–N–O angle is 108.6° in its singlet ground state. As the smallest compound, HNO is unstable in aqueous solutions, rapidly dimerizing (rate constant k ≈ 8 × 10⁶ M⁻¹ s⁻¹) to form (H₂N₂O₂), which decomposes to (N₂O), and it exhibits a pKₐ of 11.4, existing in equilibrium with its deprotonated form, the nitroxyl anion (NO⁻). This reactivity distinguishes HNO from NO, enabling it to act as both a and in biological contexts. Chemically, HNO undergoes fast reactions with soft nucleophiles such as (e.g., , k ≈ 3.1 × 10⁶ M⁻¹ s⁻¹), forming sulfinamides or disulfides, and with oxygen (k ≈ 1.8 × 10⁴ M⁻¹ s⁻¹) to produce (ONOO⁻), while also binding to metalloproteins like heme-containing enzymes (e.g., , k ≈ 2.75 × 10⁵ M⁻¹ s⁻¹). These properties have been studied through techniques like pulse radiolysis and photolysis, highlighting HNO's short (≈0.6 ms at 100 µM concentration) and its generation from donors such as Angeli's salt (Na₂N₂O₃). In biological systems, HNO modulates cardiovascular function by enhancing cardiac contractility and inducing without developing tolerance, unlike NO-based therapies, and it shows potential cardioprotective effects against ischemia-reperfusion injury through thiol modifications and interactions with signaling pathways. Ongoing research emphasizes HNO's therapeutic promise for conditions like , with advances in selective detection methods (e.g., fluorescent probes) and donor compounds to overcome its instability and enable precise delivery. Despite its enigmatic nature and historical underappreciation compared to NO, HNO's unique chemistry and position it as a key player in signaling, warranting further exploration in and .

Properties

Physical Properties

Nitroxyl (HNO) is a simple with the formula HNO and C_s , featuring a bent characteristic of its singlet . The H-N-O bond angle measures approximately 108°, reflecting the V-shaped similar to but with distinct bonding due to the nitrogen-oxygen . Experimental and computational studies have determined key bond lengths as N-O ≈ 1.21 and N-H ≈ 1.06 , consistent with a partial character in the N-O linkage and a standard N-H single bond. These structural parameters contribute to HNO's reactivity, distinguishing it from linear (NO). HNO has a significant of approximately 2.1 D, contributing to its polarity and interactions. Spectroscopic signatures provide essential tools for identifying and characterizing nitroxyl. In the , the N=O stretching vibration appears at approximately 1565 cm⁻¹, a frequency lower than that of NO (around 1876 cm⁻¹) due to the weakened from and . This band is prominent in gas-phase measurements and shifts predictably with isotopic substitution, aiding confirmation in matrix isolation experiments. reveals an absorption maximum near 350 nm, associated with π→π* transitions in the N=O moiety, though the exact position can vary slightly in due to interactions. These spectral features are crucial for detecting transient HNO in chemical and biological systems without interference from NO. The thermodynamic profile of nitroxyl underscores its instability and fleeting existence. Its high reactivity manifests in a short half-life of about 1 ms in aqueous solution at pH 7, primarily driven by rapid dimerization to hyponitrous acid (second-order rate constant ≈ 8 × 10⁶ M⁻¹ s⁻¹), though this lifetime extends at ultralow concentrations. Solubility in water is limited to around 100 μM, limited by self-reaction before saturation, while it is a polar gas under standard conditions akin to other small reactive nitrogen species. Compared to nitric oxide, HNO is the one-electron reduced and protonated form, exhibiting higher proton affinity (pK_a ≈ 11.4 for HNO/NO⁻) that favors the neutral form at physiological pH and enhances its electrophilic character.

Chemical Properties

Nitroxyl (HNO) features a ground state in which all electrons are paired in molecular orbitals or exist as s, including a non-bonding on the atom that influences its reactivity profile. This electronic configuration distinguishes HNO from (NO), which possesses a triplet ground state due to an unpaired electron in a π* orbital. HNO exhibits weak acidity, with a pK_a value of approximately 11.4 for the equilibrium HNO ⇌ NO⁻ + H⁺, ensuring that the neutral HNO species predominates under physiological conditions ( ~7.4). The chemistry of HNO is characterized by defined potentials that govern its interconversions. The standard reduction potential for the one-electron couple NO + H⁺ + e⁻ → HNO is approximately -0.14 V versus the normal electrode (NHE), facilitating the formation of HNO from NO under reducing conditions. Further two-electron reduction of HNO to (NH₂OH) occurs with E° ≈ +0.7 V for HNO + 2H⁺ + 2e⁻ → NH₂OH. In contrast, the one-electron reduction of NO to its anion NO⁻ has a more negative potential of about -0.8 V versus NHE, highlighting HNO's position as an intermediate in the nitrogen oxide ladder. The on the nitrogen atom enables HNO to behave as a , particularly in interactions with electrophilic centers such as transition metals, where it donates electrons to form coordination complexes. This nucleophilic character stands in opposition to the electrophilicity of NO, which readily accepts electrons due to its radical nature and empty π* orbital. HNO's is limited in aqueous environments, primarily due to rapid dimerization to (H₂N₂O₂), which proceeds via a second-order process with a rate constant of approximately 8 × 10⁶ M⁻¹ s⁻¹ at neutral pH. The dimer is transient and often dehydrates to (N₂O) and water.

Synthesis and Generation

Chemical Synthesis

HNO was first detected spectroscopically in 1958 by F. W. Dalby through flash photolysis of mixtures including nitric oxide and ammonia, providing initial insights into its transient nature. One of the most established laboratory routes for generating HNO involves the acid-catalyzed decomposition of Angeli's salt (Na₂N₂O₃), a diazeniumdiolate that undergoes protonation at the nitroso group, followed by tautomerization and N–N bond cleavage to yield HNO and nitrite (NO₂⁻). This process occurs efficiently at pH 4–8, with first-order kinetics (rate constant ~6.8 × 10⁻⁴ s⁻¹ at 25 °C), though below pH 4, the product shifts to nitric oxide (NO) due to further oxidation. The reaction stoichiometry is Na₂N₂O₃ + H⁺ → HNO + NaNO₂ + Na⁺, but effective HNO yields are approximately 50% owing to rapid dimerization of HNO to hyponitrous acid (k = 8 × 10⁶ M⁻¹ s⁻¹), which decomposes to N₂O and H₂O. HNO can also be produced via two-electron oxidation of (NH₂OH), a direct and clean method that avoids certain by-products associated with donor decomposition. Mild chemical oxidants, such as (N-chlorobenzenesulfonamide) or (IO₄⁻), facilitate this transformation: NH₂OH + oxidant → HNO + reduced oxidant products. For example, oxidation in acidic media proceeds through intermediate species like NH₂O• radicals, leading to HNO as a key product before further oxidation to or depending on conditions. These reactions are typically conducted in at neutral to mildly acidic , with yields ranging from 50–80% under optimized conditions, though excess oxidant can promote over-oxidation. Recent studies have shown catalytic generation of HNO from NH₂OH oxidation by using proteins like (as of 2025). Photolysis represents another controlled synthetic approach, particularly through UV irradiation of derivatives or certain compounds. For instance, UV photolysis (λ ~254 nm) of (NH₂OH) in generates HNO alongside radicals (NH₂OH → HNO + H•), though competing pathways produce , , and . More selective methods involve photo-uncaging of N-alkoxysulfonamides or Piloty's (N-hydroxybenzenesulfonamide) under UV or visible light, yielding HNO with efficiencies up to 70% in deoxygenated media. Recent advances include solid-gas reactions for generating HNO in the gas phase by contacting solid base-catalyzed HNO donors with gaseous bases (as of ). Despite these advances, achieving high-purity HNO remains challenging due to its inherent instability and propensity for dimerization, which limits overall yields to typically less than 70%. Contamination by NO is a common issue, particularly from pH-dependent side reactions in decompositions like that of Angeli's salt, necessitating inert atmospheres, low temperatures, and rapid trapping to minimize unwanted oxidation products.

Biological Generation

Nitroxyl (HNO) was first proposed as an endogenous signaling molecule in the through cardiovascular studies demonstrating its role in vasorelaxation distinct from (NO), particularly via effects of HNO donors like in aortic . Early experiments linked HNO release from such precursors to thiol-sensitive relaxation mechanisms, differentiating it from NO pathways. Enzymatic production of HNO occurs primarily through nitric oxide synthase (NOS) isoforms, which can generate HNO as a byproduct during the oxidation of the intermediate N-hydroxy-L-arginine (NOHA) to NO, especially under conditions of cofactor depletion such as low levels. This pathway has been observed in neuronal NOS (nNOS) and inducible NOS (iNOS), where uncoupling leads to partial reduction products including HNO rather than full NO formation. Non-enzymatic routes contribute to HNO generation, notably the reaction of NO with thiolates (RS⁻), such as , under conditions, yielding HNO and S-nitrosothiols (R-S-NO): \text{NO} + \text{RS}^- \rightarrow \text{HNO} + \text{R-S-NO} This mechanism is supported by kinetic studies showing efficient HNO formation in environments mimicking tissue . Mitochondrial HNO production arises from partial reduction of NO during leaks, particularly involving complex I or III, leading to HNO formation in cardiac mitochondria and contributing to signaling. HNO generation is regulated by physiological factors, including pH-dependent release from prodrugs mimicking , which accelerates HNO at pH in cellular environments. Estimated steady-state concentrations of HNO in tissues are in the low nanomolar range (~10^{-9} M), limited by rapid dimerization and scavenging by thiols. Recent reviews highlight ongoing exploration of additional enzymatic and non-enzymatic pathways in mammals and (as of ).

Reactions

Reactions with Inorganic Species

Nitroxyl (HNO) readily coordinates to metal centers, particularly iron in proteins such as . In deoxymyoglobin, featuring ferrous iron (Fe(II)), HNO binds rapidly to form a stable adduct described as {Fe(II)–NO}⁸ in Enemark–Feltham notation, where the nitrogen of HNO coordinates to the iron, and the complex exhibits dual hydrogen bonding involving the distal and a molecule for enhanced stability. The second-order rate constant for this binding is approximately 10⁷ M⁻¹ s⁻¹, indicating efficient trapping of HNO under physiological conditions. This interaction contrasts with slower binding to ferric (Fe(III)), where rates are around 10⁵–10⁶ M⁻¹ s⁻¹, highlighting the preference for reduced iron states. A prominent reaction of HNO involves its dimerization, which proceeds via second-order kinetics to form (H₂N₂O₂), subsequently decomposing to (N₂O) and water:
$2 \mathrm{HNO} \rightarrow \mathrm{H_2N_2O_2} \rightarrow \mathrm{N_2O + H_2O}
The rate constant for dimerization is approximately 8 × 10⁶ M⁻¹ s⁻¹ at neutral , making it a dominant pathway in aqueous solutions without trapping agents. This process is -dependent; at acidic , protonated HNO favors rapid dimerization, while at higher (>7), deprotonation to NO⁻ slows the due to electrostatic repulsion, though the overall kinetics remain influenced by acid-base equilibria of the dimer. The isomer of predominates and decomposes more readily than the trans form.
HNO also undergoes oxidation by molecular oxygen (O₂) in aerated solutions to form (ONOO⁻):
\mathrm{HNO + O_2 \rightarrow HOONO}
(leading to ONOO⁻ + H⁺). This reaction exhibits a second-order rate constant of 1.8 × 10⁴ M⁻¹ s⁻¹ at physiological (7.4), underscoring its relevance in oxygenated aqueous environments. This pathway predominates in neutral solutions, with as the major product, though under certain conditions HNO may contribute to NO production via secondary reactions.
In reductive environments, such as conditions, HNO can be further reduced to (NH₂OH):
\mathrm{HNO + 2e^- + 2H^+ \rightarrow NH_2OH}
This two-electron, two-proton process is thermodynamically favorable and occurs via like the , relevant in biological systems lacking oxygen where HNO serves as an in nitrogen metabolism. The reaction highlights HNO's role in cascades, though specific rate constants vary with the and .

Reactions with Organic and Biological Molecules

Nitroxyl (HNO) displays pronounced reactivity toward s, which are abundant nucleophilic sites in organic and biological contexts, often leading to modification of proteins and small molecules. The primary mechanism involves the electrophilic attack of HNO on the thiolate (RS⁻), forming an N-hydroxysulfenamide intermediate (RSNHOH) with a second-order rate constant on the order of 10⁶ M⁻¹ s⁻¹ at physiological pH, as observed for (GSH) and (Cys). This intermediate can follow two main pathways: rearrangement to a sulfinamide (RS(O)NH₂), which is irreversible and results in permanent oxidation, or reaction with a second molecule to yield a (RSSR) and (NH₂OH). In protein environments, HNO can also interact with s (RSSR) via nucleophilic attack, potentially generating thiolate (RS⁻) and N-hydroxysulfenamide (RSNOH) species, thereby facilitating - exchange and contributing to signaling disruptions. Similarly, HNO reacts with S-nitrosothiols (RSNO), promoting denitrosation and formation while altering availability in biological systems. These modifications are central to HNO's biological effects, such as inactivation without depleting global pools like GSH. HNO also engages primary amines, albeit more slowly, forming N-hydroxy adducts that may decompose to diazenium species or deaminated products. The rate constants for these reactions are approximately 10² M⁻¹ s⁻¹, significantly lower than those for thiols, reflecting HNO's preference for softer nucleophiles like over . This selectivity limits amine reactions in crowded biological milieus but allows targeted modifications in amine-rich environments, such as backbones. A diagnostic tool for HNO detection involves its rapid trapping by phosphines (PR₃), proceeding via to yield an aza-ylide (R₃P=NOH) and (OPR₃), with subsequent or to stable adducts for quantitation. This reaction exhibits second-order rate constants around 10⁶–10⁷ M⁻¹ s⁻¹, enabling selective capture in aqueous media even amid competing biomolecules. For example, triphenylphosphine trisulfonate (TPPTS) traps HNO generated enzymatically, producing quantifiable amides via Staudinger ligation. In biomolecules, HNO demonstrates selectivity for vicinal thiols in proteins, such as the Cys-149 and Cys-152 residues in the of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). This preferential reactivity, with rates exceeding 10⁹ M⁻¹ s⁻¹ due to proximity effects, leads to intramolecular formation or sulfinamide generation, irreversibly inhibiting activity at micromolar HNO concentrations without requiring oxygen. GAPDH inhibition persists even in the presence of excess GSH, highlighting HNO's ability to target specific protein thiols over free thiols. Overall, HNO's reactivity follows a kinetic favoring thiols (k ≈ 10⁶ M⁻¹ s⁻¹) over transition metals (k up to 10⁷ M⁻¹ s⁻¹) and alkenes (k < 10³ M⁻¹ s⁻¹), which underscores its short (~0.05 s) in thiol-rich media but extension to seconds in thiol-depleted conditions, enhancing for selective biological interactions.

Detection

Spectroscopic Detection

Nitroxyl (HNO) exhibits weak ultraviolet-visible (UV-Vis) absorption, enabling transient monitoring in aqueous solutions using time-resolved techniques such as laser flash photolysis, where HNO is generated photochemically from precursors like Angeli's salt (Na₂N₂O₃). Direct (EPR) detection of HNO is precluded by its diamagnetic singlet ground state, lacking unpaired electrons. Indirect EPR detection of HNO-derived species is possible in chemical and biological systems. (IR) spectroscopy provides a means to identify HNO through its vibrational modes, particularly the N=O stretching frequency (ν₂) observed at approximately 1468 cm⁻¹ in the gas phase. This band is distinctly lower than the N=O stretch of (NO) at 1876 cm⁻¹, facilitating differentiation between the two species. Such measurements are typically conducted under controlled conditions to stabilize transient HNO. Raman spectroscopy, particularly surface-enhanced Raman scattering (SERS), enhances detection sensitivity for HNO at low concentrations in solution by leveraging nanostructured surfaces to amplify scattering signals. This approach has been applied to HNO-metal complexes, revealing N=O stretches in the 1335–1493 cm⁻¹ range, offering potential for monitoring in complex media. The short lifetime of HNO, governed by rapid dimerization (k ≈ 8 × 10⁶ M⁻¹ s⁻¹), necessitates time-resolved spectroscopic techniques for its observation, with typical detection sensitivities on the order of 10⁻⁶ M limited by its reactivity and weak absorptivities.

Other Detection Methods

One indirect method for detecting nitroxyl (HNO) involves chemical trapping with , which reacts rapidly and selectively with HNO to form an aza-ylide intermediate and . The aza-ylide can be subsequently detected by ³¹P NMR , where it exhibits a characteristic downfield relative to the starting (typically around 30-35 for analogous ylides). This approach allows for quantification of HNO in aqueous solutions and has been applied to confirm HNO generation from donors like Angeli's salt, with minimal interference from (NO) due to the slower reaction kinetics with phosphines. Electrochemical detection of HNO employs amperometric sensors based on HNO-selective electrodes, such as those modified with cobalt(III) porphyrins. These sensors operate by HNO binding to the Co(III) center, forming a transient Co(III)-NO⁻ complex that undergoes oxidation at approximately 0.8 V vs. saturated calomel electrode (SCE), generating a measurable current proportional to HNO concentration in the nanomolar range. The method distinguishes HNO from NO, as NO binds preferentially to the reduced Co(II) form, enabling selective real-time monitoring in biological matrices like cell cultures. Mass spectrometry provides another indirect route for HNO detection, particularly through membrane inlet (MIMS), where HNO is identified by the m/z 31 corresponding to [HNO]⁺ in the gas phase. For liquid samples, derivatization with trapping agents like phosphines followed by LC-MS detects HNO-derived products, such as adducts at specific m/z values (e.g., m/z 444 for certain ligated ). This technique has been validated for quantifying HNO release from donors in aqueous media, with sensitivity down to micromolar levels. HNO induces Ca²⁺ release from intracellular stores, such as the via oxidation of ryanodine receptors. This effect can be indirectly monitored in cellular systems using Ca²⁺-sensitive probes. Recent advances include near-infrared fluorescent probes for real-time visualization of HNO in living systems, such as in plant stress responses (as of 2025), and reusable electrochemical sensors based on Cu cyclam complexes for nanomolar detection (as of 2024). To ensure specificity, these detection methods are validated by comparison to NO-selective assays, such as hemoglobin autoxidation or Cu²⁺-based fluorogenic probes, confirming low (e.g., <5% response to equivalent NO concentrations in phosphine trapping and electrochemical sensors).

Biological and Medicinal Significance

Role in Physiology

Nitroxyl (HNO) plays a significant role in by promoting through activation of soluble (sGC). Unlike (NO), which binds to the iron of sGC to stimulate (cGMP) production, HNO interacts directly with the ferrous of sGC, leading to enhanced enzyme activity and elevated cGMP levels that induce vascular relaxation. This mechanism is independent of NO pathways and requires functional sGC, as demonstrated in sGC-deficient models where HNO-induced is abolished. In , HNO exerts cardioprotective effects by enhancing positive inotropy, particularly in models. It achieves this by targeting cysteines 41 and 46 on phospholamban, promoting bond formation that relieves inhibition of the Ca²⁺-ATPase (SERCA2a), thereby accelerating Ca²⁺ reuptake into the and improving . This modification occurs at physiological HNO-to-thiol ratios, resulting in reversible enhancements to Ca²⁺ cycling without reliance on β-adrenergic receptor signaling. HNO contributes to antioxidant defense in physiological conditions by exhibiting low reactivity toward superoxide (O₂⁻•), with a rate constant orders of magnitude slower than that of NO (versus 6.7 × 10⁹ M⁻¹ s⁻¹ for NO), allowing HNO to persist in oxidative environments without forming harmful peroxynitrite (ONOO⁻). This resistance to scavenging enables HNO to mitigate oxidative stress in cardiovascular tissues, potentially by inhibiting enzymes like NADH oxidase that generate superoxide. Through cellular signaling, HNO modulates ion channels in vascular , including activation of voltage-gated K⁺ (K_V) and ATP-sensitive K⁺ (K_ATP) channels, which promotes hyperpolarization and contributes to vasorelaxation. Additionally, HNO serves as an alternative to NO-mediated protein S-nitrosation by inducing thiol-based modifications such as disulfide bond formation or sulfinamide generation on residues, altering protein function in a redox-sensitive manner distinct from group addition. Endogenous HNO is detectable at low concentrations in the nanomolar range in cardiac tissue, with potential elevations under physiological stress conditions such as ischemia, supporting its role in adaptive signaling responses.

Therapeutic Applications

Nitroxyl (HNO) donors have emerged as promising therapeutic agents primarily for cardiovascular conditions, particularly (ADHF), due to their ability to enhance cardiac contractility and relaxation without the drawbacks associated with traditional inotropes or (NO) donors. Early development focused on compounds like CXL-1020 (1-nitrosocyclohexyl acetate), a pure HNO that demonstrated positive inotropic and lusitropic effects in preclinical models and phase I/IIa clinical trials conducted in the . In these trials, intravenous of CXL-1020 reduced left and right heart filling pressures, systemic , and improved in patients with systolic , while maintaining stability. Subsequent advancements led to second-generation HNO donors, such as cimlanod (BMS-986231), developed by Bristol-Myers Squibb following their 2015 acquisition of Cardioxyl Pharmaceuticals. Cimlanod has shown hemodynamic benefits in phase II trials for ADHF, including , reduced pulmonary wedge pressure, and improved , with reasonable tolerability at doses up to 6 μg/kg/min. A 2023 mechanistic trial further indicated that cimlanod influences response in congested patients, though it may attenuate when combined with . Preclinical studies also support HNO donors' potential in mitigating ischemia-reperfusion injury by preserving myocardial function and reducing infarct size through thiol-dependent mechanisms. Compared to NO donors like , HNO donors offer advantages such as lack of tolerance development and minimal , attributed to HNO's chemical stability, including resistance to scavenging by and lack of dependence on enzymatic bioactivation, despite activation of soluble . This profile positions HNO as a complementary option for ADHF management, where NO donors often fail due to and excessive . In , efforts have centered on designing pH-sensitive HNO prodrugs that selectively release HNO in acidic environments, such as tumor microenvironments ( 6.0–7.0), to exploit cancer-specific conditions for . For instance, ionic liquid-based HNO donors have been engineered to modulate intratumoral states and inhibit tumor progression in preclinical models. Despite these benefits, challenges persist, including potential toxicity from off-target reactions with thiols, which can inhibit enzymes like and lead to at high concentrations. Ongoing clinical development, with phase II evaluations of cimlanod completed as of 2025, including hemodynamic benefits and mechanistic insights, aims to address these issues through optimized dosing and delivery; phase III trials are planned. HNO's therapeutic promise builds on its endogenous cardioprotective roles, but drug-based applications remain the focus for clinical translation.

References

  1. [1]
    The Chemistry of HNO: Mechanisms and Reaction Kinetics - Frontiers
    This review is focused on the chemistry of HNO, with emphasis on reaction kinetics and mechanisms in aqueous solutions.
  2. [2]
    Recent Advances in the Chemical Biology of Nitroxyl (HNO ... - NIH
    Nitroxyl avidly reacts with soft nucleophiles, especially thiols, to yield either disulfides or sulfinamides and many of the observed biological effects of HNO ...
  3. [3]
    The Physiological Chemistry and Biological Activity of Nitroxyl (HNO)
    The physiological chemistry and biological activity of Nitroxyl (HNO): The neglected, misunderstood, and enigmatic nitrogen oxide.
  4. [4]
  5. [5]
    Ab initio study of nitroxide, HNO - AIP Publishing
    Dec 15, 1993 · A bent geometry is obtained for HNO−, with an equilibrium bond angle of 106.2°, and bond lengths of RNO=1.333 Å and RNH=1.045 Å. The calculated ...
  6. [6]
    The infrared spectrum of HNO - Canadian Science Publishing
    Complete analyses have been made of the ν1 bands of HNO and DNO with the following results (in cm−1). Spectra of ν2 (NO stretching) were also observed in both ...
  7. [7]
    Photolysis of Nitromethane and of Methyl Nitrite in an Argon Matrix
    The vibrational frequencies of HNO (1570 and 1110 cm‐1) and DNO (1560 and 822 cm‐1) correspond to a bent molecule with a double bond between the nitrogen and ...
  8. [8]
    Nitroxyl and its anion in aqueous solutions: Spin states ... - PNAS
    At 20 mM HCO and pH 7, the half-life of the 300-nm band decreased to 20 ms, which corresponds to the half-life of authentic peroxynitrite under these ...Missing: solubility boiling
  9. [9]
    Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct ...
    Angeli's salt releases HNO with a half-life of approximately 2-3 min at physiological pH and temperature. Nitroxyl release from this compound is observed ...Missing: boiling point
  10. [10]
    A recent history of nitroxyl chemistry, pharmacology and therapeutic ...
    Conversion of nitroxyl (HNO) to nitric oxide in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO.Missing: tautomer affinity<|control11|><|separator|>
  11. [11]
    HNO Signaling Mechanisms - Jon M. Fukuto, Samantha J ...
    The nitrogen center of HNO is electrophilic (akin to the carbon atom of a carbonyl function) and, therefore, can react with nucleophiles. However, the lone pair ...
  12. [12]
    On the acidity and reactivity of HNO in aqueous solution and ... - PNAS
    The ground-state triplet nature of NO− affects the rates of acid-base chemistry of the HNO/NO− couple. HNO is highly reactive toward dimerization and addition ...
  13. [13]
    Azanone (HNO): generation, stabilization and detection
    Jul 5, 2021 · Azanone (HNO), or nitroxyl, is a one-electron reduced and protonated form of nitric oxide. It is generated from nitric oxide and is unstable, ...2. Hno Generation · 3.1 Metalloporphyrins · 4. Hno Detection MethodsMissing: boiling | Show results with:boiling
  14. [14]
    The Chemistry of Nitroxyl-Releasing Compounds - PMC - NIH
    1-Nitrosocyclohexyl acetate displays a UV-vis absorbance λmax at 667 nm (ɛ=20.7 M−1 cm−1) and infrared absorbances for C=O at ν=1750 cm−1 and N=O at ν ...
  15. [15]
  16. [16]
    Periodate Oxidation of Hydroxylamine Derivatives. Products, Scope ...
    Production of reactive oxygen species by the reaction of periodate and hydroxylamine for rapid removal of organic pollutants and waterborne bacteria.Missing: HNO | Show results with:HNO
  17. [17]
    Photolysis of hydroxylamine in aqueous solution - ACS Publications
    Photolysis of hydroxylamine in aqueous solution. Click to copy article ... Oxidation Mechanism of Hydroxamic Acids Forming HNO and NO. 2015, 315-333 ...
  18. [18]
  19. [19]
  20. [20]
  21. [21]
  22. [22]
    Spin-Forbidden Deprotonation of Aqueous Nitroxyl (HNO)
    Aug 6, 2025 · ... protonation of NO − that occurs due to the weak acidity of nitroxyl, pK a (HNO/NO − ) ≈ 11.4. 75 The pathway occurs under slightly basic ...
  23. [23]
    Decoding the enigmatic last gasotransmitter. The intriguing journey ...
    O stretching in 1HNO is about 200 cm−1 lower than that in ●NO. Finally, azanone is a weak acid with a reported pKa between 11.4 and 11.6 [[14], [15], [16]], ...
  24. [24]
    Kinetics of HNO reactions with O2 and HNO - ScienceDirect
    Rate constants for the reactions (i) HNO+O2→k1 products, (ii) HNO+HNO→k2products have been measured over a temperature range 296-421 K using the developed ...
  25. [25]
    Nitroxyl (HNO) Reacts with Molecular Oxygen and Forms ... - NIH
    UV-visible Absorption Measurements. The UV-visible absorption spectra were collected with Agilent 8453 spectrophotometer equipped with photodiode array ...
  26. [26]
    [PDF] The catalytic reduction of nitrate and nitric oxide to hydroxylamine
    Jan 1, 1979 · At very negative potentials evolution of hydrogen was observed. A 3- step mechanism to hydroxylamine was proposed via HNO and HNOH. Ammonia.
  27. [27]
    The Chemistry of HNO: Mechanisms and Reaction Kinetics - PMC
    HNO is a simple triatomic molecule and its structure is described by three geometrical parameters: the N-O bond length rN-O, the N-H bond length rN-H and the ...
  28. [28]
    Computational investigation of the reaction mechanisms of nitroxyl ...
    Jun 18, 2010 · The reaction of HNO with thiols has been shown to lead to disulfides and sulfinamides. The free energies of reaction (DeltaG) and activation ( ...
  29. [29]
    Reaction between S-nitrosothiols and thiols: generation of nitroxyl ...
    We find that S-nitrosothiols can react with thiols to generate nitroxyl (HNO) and the corresponding disulfide. Further reaction of HNO with the remaining S- ...
  30. [30]
    HNO Is Produced by the Reaction of NO with Thiols - PubMed
    Oct 18, 2017 · These reactions have been historically discarded due to the negative redox potential for the NO,H+/HNO couple. However, the NO to HNO conversion ...
  31. [31]
    The Pharmacology of Nitroxyl (HNO) and Its Therapeutic Potential
    Nitroxyl (HNO), the one-electron reduced and protonated congener of nitric oxide (NO), has received recent attention as a potential pharmacological agent ...Missing: prototropic | Show results with:prototropic
  32. [32]
    Rapid and selective nitroxyl (HNO) trapping by phosphines - NIH
    This phosphine successfully trapped HNO generated via HRP-mediated oxidation of NH2OH to give the identical ligation products.
  33. [33]
    The inhibition of glyceraldehyde-3-phosphate dehydrogenase by ...
    The inhibition of glyceraldehyde-3-phosphate dehydrogenase by nitroxyl (HNO). Author links open overlay panel. Brenda E. Lopez a , David A. Wink, Jon M ...Results And Discussion · Inhibition Of Gapdh... · Oxygen Dependency Of Hno...
  34. [34]
    Nitrosyl hydride
    ### Summary of Physical Properties of HNO (Nitrosyl Hydride)
  35. [35]
    NMR, IR/Raman, and Structural Properties in HNO and RNO ... - NIH
    Here, we report a quantum chemical investigation of the 1H and 15N NMR chemical shifts and NO vibrational frequencies in synthetic HNO and RNO heme complexes, ...
  36. [36]
    Reductive Phosphine-Mediated Ligation of Nitroxyl (HNO)
    ### Summary of HNO Trapping with Triphenylphosphine
  37. [37]
    Comparison of Reductive Ligation‐Based Detection Strategies for Nitroxyl (HNO) and S‐Nitrosothiols
    **31P NMR Chemical Shift for Aza-Ylide Formed from HNO and Phosphine:**
  38. [38]
    Detection and quantification of nitric oxide–derived oxidants in ...
    Cobalt(III) porphyrins react with HNO and constitute the basis of an amperometric electrochemical sensor for HNO (Fig. ... Detection of nitroxyl (HNO) by membrane ...
  39. [39]
    Detection of nitroxyl (HNO) by membrane inlet mass spectrometry
    May 15, 2011 · Membrane inlet (or introduction) mass spectrometry (MIMS) was used to detect nitroxyl (HNO) in aqueous solution for the first time.Missing: review methods spectroscopic
  40. [40]
    Mechanism-Based Triarylphosphine-Ester Probes for Capture of ...
    Instead, we observed a new LC–MS peak at m/z = 444.1029. On the basis of 1H ... Recent advances in the chemical biology of nitroxyl (HNO) detection and generation ...
  41. [41]
    Protein-Based Ca2+ Indicators—Section 19.5 - US
    Aequorin is not exported or secreted, nor is it compartmentalized or sequestered within cells; thus, aequorin measurements can be used to detect Ca2+ changes ...
  42. [42]
  43. [43]
  44. [44]
  45. [45]
    Nitroxyl (HNO) | Circulation: Heart Failure
    Nov 19, 2013 · CXL-1020 is stable (>95%) in aqueous solution at pH <4.5 for ≥24 hours and soluble to ≈1 mg/mL in water for injection, 5% dextrose, and 0.9% ...<|separator|>
  46. [46]
    Nitroxyl (HNO) for treatment of acute heart failure - PubMed
    These findings support the concept of nitroxyl donors as attractive agents for the treatment of acute decompensated heart failure. Publication types. Review ...Missing: applications | Show results with:applications
  47. [47]
    Intravenous Infusion of CXL-1020, a Novel Nitroxyl (HNO) Donor ...
    Intravenous Infusion of CXL-1020, a Novel Nitroxyl (HNO) Donor, Improves Left Ventricular Systolic and Diastolic Function in Dogs with Advanced Heart Failure.
  48. [48]
    Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
    Nov 2, 2015 · Bristol-Myers Squibb will acquire all of the issued and outstanding capital stock of Cardioxyl, a private biotechnology company focused on the discovery and ...
  49. [49]
    Effects of a Novel Nitroxyl Donor in Acute Heart Failure - JACC
    Nov 24, 2020 · Cimlanod at a dose of 6 μg/kg/min was reasonably well-tolerated compared with placebo. Cimlanod reduced markers of congestion, but this did not persist beyond ...
  50. [50]
    New cimlanod trial provides insights into mechanistic effects of ...
    Dec 20, 2023 · Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS-986231). Eur J Heart ...
  51. [51]
    Nitroxyl affords thiol-sensitive myocardial protective effects akin to ...
    The effects of nitroxyl (HNO/NO−), the one-electron reduction product of NO, on ischemia/reperfusion (I/R) injury are unknown. Here we investigated whether HNO/ ...
  52. [52]
    Nitroxyl (HNO): the Cinderella of the nitric oxide story - PubMed
    ... scavenging by superoxide (*O2-) and tolerance development. HNO donors are protective in the setting of heart failure in which NO donors have minimal impact.
  53. [53]
    Nitroxyl (HNO): the Cinderella of the nitric oxide story - Cell Press
    Oct 3, 2008 · Nitrergic relaxation in urethral smooth muscle: involvement of potassium channels and alternative redox forms of NO. Naunyn Schmiedebergs ...
  54. [54]
    Nitroxyl as a Potential Theranostic in the Cancer Arena
    HNO donors have been revealed to restrain the proliferation of breast cancer cells (107). HNO donors could also trigger cancer cell apoptosis and retard tumor ...
  55. [55]
    Design and tuning of ionic liquid–based HNO donor through ...
    Nov 6, 2020 · The IL-based HNO donors exert pharmacological potential to inhibit tumor progression by regulating intratumoral redox state.
  56. [56]
    A mechanistic trial of cimlanod (BMS-986231) - PubMed
    Conclusions: For patients with heart failure and congestion, vasodilatation with agents such as cimlanod reduces the response to diuretic agents, which may ...
  57. [57]
    From Heaven to Heart: Nitroxyl (HNO) in the Cardiovascular System ...
    One aim of this chapter is to put the following three fundamental chemical properties of HNO in a cardiovascular physiology and therapeutic perspective: (1) HNO ...